Corbus Pharmaceuticals Holdings Inc (CRBP)
44.96
-0.24
(-0.53%)
USD |
NASDAQ |
May 22, 16:00
44.09
-0.87
(-1.94%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings Price to Book Value: 4.979 for May 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 21, 2024 | 4.982 |
| May 20, 2024 | 5.351 |
| May 17, 2024 | 4.960 |
| May 16, 2024 | 5.061 |
| May 15, 2024 | 4.865 |
| May 14, 2024 | 4.738 |
| May 13, 2024 | 4.725 |
| May 10, 2024 | 4.738 |
| May 09, 2024 | 4.821 |
| May 08, 2024 | 4.672 |
| May 07, 2024 | 4.383 |
| May 06, 2024 | 4.278 |
| May 03, 2024 | 4.273 |
| May 02, 2024 | 4.139 |
| May 01, 2024 | 4.036 |
| April 30, 2024 | 4.014 |
| April 29, 2024 | 3.862 |
| April 26, 2024 | 3.711 |
| April 25, 2024 | 3.630 |
| April 24, 2024 | 3.851 |
| April 23, 2024 | 4.090 |
| April 22, 2024 | 4.085 |
| April 19, 2024 | 4.252 |
| April 18, 2024 | 3.958 |
| April 17, 2024 | 4.027 |
| Date | Value |
|---|---|
| April 16, 2024 | 4.456 |
| April 15, 2024 | 4.629 |
| April 12, 2024 | 4.426 |
| April 11, 2024 | 4.334 |
| April 10, 2024 | 4.134 |
| April 09, 2024 | 4.060 |
| April 08, 2024 | 4.352 |
| April 05, 2024 | 4.331 |
| April 04, 2024 | 4.223 |
| April 03, 2024 | 4.172 |
| April 02, 2024 | 4.059 |
| April 01, 2024 | 4.117 |
| March 28, 2024 | |
| March 27, 2024 | |
| March 26, 2024 | |
| March 25, 2024 | |
| March 22, 2024 | |
| March 21, 2024 | |
| March 20, 2024 | |
| March 19, 2024 | |
| March 18, 2024 | |
| March 15, 2024 | |
| March 14, 2024 | |
| March 13, 2024 | |
| March 12, 2024 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2706
Minimum
Mar 10 2023
95.15
Maximum
Nov 30 2023
11.52
Average
3.045
Median
Price to Book Value Benchmarks
| AIM ImmunoTech Inc | 5.088 |
| Perspective Therapeutics Inc | 4.036 |
| Protalix BioTherapeutics Inc | 3.175 |
| Electromed Inc | 3.363 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 157.23 |
| Price | 44.96 |
| Earnings Yield | -15.36% |
| Market Cap | 480.47M |